Role of alpha-catenin and Wnt signaling in regulating lipid homeostasis

Information

  • Research Project
  • 10248472
  • ApplicationId
    10248472
  • Core Project Number
    R01GM129266
  • Full Project Number
    5R01GM129266-05
  • Serial Number
    129266
  • FOA Number
    PA-16-160
  • Sub Project Id
  • Project Start Date
    9/1/2018 - 6 years ago
  • Project End Date
    8/31/2022 - 2 years ago
  • Program Officer Name
    XU, JIANHUA
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
  • Award Notice Date
    8/27/2021 - 3 years ago
Organizations

Role of alpha-catenin and Wnt signaling in regulating lipid homeostasis

Title: Role of ?-catenin and Wnt signaling in regulating lipid homeostasis Project Summary: Wnt signaling, normally limited to embryogenesis, stem cell renewal and wound healing, is inappropriately re- employed in a variety of human cancers, such as hepatocellular carcinoma and colorectal cancer, as well as other diseases. Aberrant Wnt signaling and altered lipid metabolism are both signs of oncogenesis, and recent data suggest that Wnt control of adipogenesis and lipid metabolism may occur through separate mechanisms. Currently, the mechanisms remain poorly understood, and so remain outside of our ability to monitor, mitigate, prevent, or correct. It has been impossible to clearly delineate separate functions of Wnt in adipogenesis, lipid anabolism, and lipid catabolism, because these processes are inextricably interconnected in mammals. To circumvent this limitation, we use Drosophila as a primary experimental system, which provides unparalleled sophistication in manipulating Wnt (Wingless in Drosophila) activity in vivo. More importantly, the unique temporal separation of adipogenesis, lipogenesis, lipolysis, and fatty acid ?-oxidation during the Drosophila life cycle allows us to precisely monitor and manipulate these fundamental processes. Our genetic analyses of Axin and ?-catenin, two components of the Wnt signaling pathway, have revealed that Wnt signaling regulates lipid homeostasis during the late larval stage, separately from adipogenesis completed during embryogenesis. We have confirmed that the phenotypes of Axin mutants are caused by a gain of the canonical Wnt activity, elevated expression of ?-catenin target genes, and altered expression of genes encoding enzymes involved in lipid catabolism. By screening a library of diverse FDA-approved drugs, we discovered that both the defective lipid homeostasis and the hyperactive Wnt signaling are potently suppressed by peptide boronic acids, a class of proteasome inhibitors. The suppressive effects of these inhibitors are dependent on ?-catenin. Despite the important role of ?-catenin in Wnt signaling, the precise mechanisms that normally regulate the stability of ?- catenin remain unclear. Thus the objective of this proposal is to determine how ?-catenin stability in particular, and Wnt signaling in general, regulates lipid catabolism. We will identify the molecular and cellular mechanisms that control the stability of ?-catenin in Drosophila by analyzing fat deposition and lipid accumulation. Our investigations will define the molecular mechanism(s) that control the stability of ?-catenin and reveal how Wnt signaling regulates lipid mobilization and lipid catabolism, thereby advancing our understanding of the tumor suppressive effects of ?-catenin and how Wnt signaling regulates lipid homeostasis.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    200000
  • Indirect Cost Amount
    104000
  • Total Cost
    304000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIGMS:304000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ICI
  • Study Section Name
    Intercellular Interactions Study Section
  • Organization Name
    TULANE UNIVERSITY OF LOUISIANA
  • Organization Department
    BIOCHEMISTRY
  • Organization DUNS
    053785812
  • Organization City
    NEW ORLEANS
  • Organization State
    LA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    701185665
  • Organization District
    UNITED STATES